Relay Therapeutics, Inc. ($RLAY)
Filing Information
| Accession Number | 0001193125-26-281059 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
280,368
Total Value
$1,968,183.36
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 93,456 | $4.12 | $385,038.72 | 512,013 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Jun 22, 2026 | Sale | 93,456 | $16.94 | $1,583,144.64 | 418,557 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 93,456 | $0.00 | $0.00 | 0 | Direct | โ | View Details |